Spot on again.
Mithra is the party that had to collect more data for the FDA and at the time responded that the request was unusual.
Everyone here can look up the exact phrasing.
I think SR couldn't exactly fingerpoint to their partner and blame Mithra for the delay or say the FDA is being overly zealous or maybe even obstructing the approval to give other players an advantage... you never know.
The criticism I do have is that this information is extemely poorly communicated.
I really hope the new chair can work wonders and realise that the communication of this company is pathetic.
For example I couldn't even find any confirmation of the gNuvaring CRL response that was done in March anywhere untill this was confirmed in the investor call the other day.
Nor do we even know to this day, why the gNuvaring was delayed.
Potentially exciting times ahead or another kick in the balls, my money is on the former.
Spot on again.Mithra is the party that had to collect more data...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.48 |
Change
0.070(1.59%) |
Mkt cap ! $381.1M | |||
| Open | High | Low | Value | Volume |
| $4.43 | $4.54 | $4.42 | $1.026M | 230.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 154 | $4.46 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.50 | 16238 | 2 |
View Market Depth
| Last trade - 16.10pm 03/07/2024 (20 minute delay) ? |
| MYX (ASX) Chart |